Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP12 | P39900 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 7/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.33 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | BLM | P54132 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27405675 | 0.87 | CES2 (0.34) | MMP1MMP9MMP12ALDH1A1CES2 | |
| SCHEMBL4880742 | 0.82 | — | — | |
| SCHEMBL29377475 | 0.71 | — | — | |
| SCHEMBL1326408 | 0.71 | TP53 (0.41) | MMP1MMP9MMP12CA1CA9 | |
| Water SCHEMBL29272692 | 0.69 | TP53 (0.39) | MMP1MMP9MMP12CA1CA9 | |
| Water SCHEMBL29272691 | 0.69 | TP53 (0.39) | MMP1MMP9MMP12CA1CA9 | |
| SCHEMBL188762 | 0.68 | MMP1 (0.35) | MMP1MMP9MMP12CA1CA9 | |
| SCHEMBL6990198 | 0.68 | — | — | |
| SCHEMBL827212 | 0.67 | — | — | |
| SCHEMBL10495916 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080070868-A1 | Novel Thiazole Inhibitors of Fructose 1,6-bisphosphatase | METABASIS THERAPEUTICS, INC. (US) | 2008-03-20 | — | — | US | disclosed |
| US-20070225259-A1 | Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase | METABASIS THERAPEUTICS, INC. | 2007-09-27 | — | — | US | disclosed |
| EP-1778250-A2 | NOVEL THIAZOLE INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE | Metabasis Therapeutics, Inc. (US) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006023515-A2 | NOVEL THIAZOLE INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE | METABASIS THERAPEUTICS, INC. (US) | 2006-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225259-A1 | Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase | FBP1, PFKFB1, ALDOA | MMP1 1952/4885MMP9 2734/4885MMP12 2498/4885 |
| US-20080070868-A1 | Novel Thiazole Inhibitors of Fructose 1,6-bisphosphatase | FBP1, ALDOA, SLC5A1 | MMP1 1041/4885MMP9 1802/4885MMP12 1800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.